Subcortical targets involved in the action of psilocybin in learned and innate escape behaviors
皮层下目标参与裸盖菇素在习得和先天逃避行为中的作用
基本信息
- 批准号:10678202
- 负责人:
- 金额:$ 3.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-16 至 2026-04-15
- 项目状态:未结题
- 来源:
- 关键词:AcuteAddressAttentionBehaviorBehavioralBehavioral ParadigmBiological AssayBrainBrain regionClinicalClinical TreatmentClinical TrialsDataDiseaseDorsalDoseExhibitsGeneticHallucinogensHippocampusImmediate-Early GenesInnovative TherapyKnowledgeLearned HelplessnessLearningMajor Depressive DisorderMapsMeasuresMediatingMental DepressionMood DisordersMusNeocortexNeurobiologyPatientsPatternPhysiciansPropertyPsilocybinPsychiatryResearchRoleSalineScientistSiliconStimulusStructureTestingThalamic structureTimeTrainingViralWorkantidepressant effectclinical effectdensitydesigner receptors exclusively activated by designer drugsdisabilityearly phase clinical trialexperienceexperimental studyin vivointerestmind controlneocorticalneuralneural circuitnovelskillstool
项目摘要
PROJECT TITLE
Subcortical targets involved in the action of psilocybin in learned and innate escape behaviors
PROJECT SUMMARY
Mood disorders such as depression now represent a leading cause of disability throughout the world,
with conventional first-line treatments failing to provide relief for most patients. In recent years, novel
treatments with fast-acting properties have garnered significant interest as innovative therapies. The
psychedelic psilocybin, in particular has recently gained attention for its ability to produce substantial and rapid
antidepressant effects in early-phase clinical trials. This combination of increasing need and exciting
preliminary clinical results has led to the recent ‘breakthrough therapy’ status designation for psilocybin to be
studied as a treatment for major depressive disorder. Yet despite these exciting results in pilot clinical trials, the
neurobiology underlying the effect of psilocybin remains less understood. Thus, a critical opportunity to further
our understanding of the action of psilocybin will be addressed here.
Among early studies examining the mechanisms of action of psilocybin, most have focused on the
neocortex and hippocampus. However, previous cellular and circuit-level research has clearly implicated
subcortical structures as key in the action of psilocybin. Our own preliminary work using whole-brain cFos
mapping has identified several candidate subcortical regions that are modulated by psilocybin. Aim 1 will
determine the activity of two of these key subcortical brain regions via in vivo recording with high-density silicon
probes to determine how neural activity changes following systemic psilocybin administration. Aim 2 will use
causal manipulation during psilocybin treatment to determine the relative role of subcortical regions during
innate and learned escape behaviors in mice. Specifically, chemogenetics will be used to bidirectionally control
brain region activity during a looming stimulus and learned escape behavioral paradigms. Cumulatively, this
work will determine the relative roles of key subcortical brain regions in the action of psilocybin during escape
behaviors and expand the framework for psilocybin’s use in clinical treatment.
项目名称
皮层下目标参与裸盖菇素在习得和先天逃避行为中的作用
项目概要
抑郁症等情绪障碍现已成为全世界残疾的主要原因,
近年来,传统的一线治疗未能为大多数患者提供缓解。
具有速效特性的治疗作为创新疗法引起了人们的极大兴趣。
致幻剂裸盖菇素最近因其能够产生大量且快速的能力而受到关注
早期临床试验中的抗抑郁作用不断增加的需求和令人兴奋的结合。
初步临床结果导致裸盖菇素最近获得“突破性疗法”地位
研究用于治疗重度抑郁症然而,尽管试点临床试验取得了这些令人兴奋的结果,但
裸盖菇素作用背后的神经生物学仍然知之甚少,因此,这是进一步研究的关键机会。
我们对裸盖菇素作用的理解将在此阐述。
在检查裸盖菇素作用机制的早期研究中,大多数都集中在
然而,之前的细胞和回路水平研究已经明确暗示了这一点。
我们自己使用全脑 cFos 进行的初步工作是皮层下结构是裸盖菇素作用的关键。
映射已识别出受裸盖菇素调节的几个候选皮层下区域。
通过高密度硅体内记录确定两个关键皮层下大脑区域的活动
目标 2 将使用探针来确定全身注射裸盖菇素后神经活动如何变化。
裸盖菇素治疗期间的因果操作以确定皮层下区域在治疗期间的相对作用
具体来说,化学遗传学将用于双向控制小鼠的先天和后天逃避行为。
迫在眉睫的刺激期间大脑区域的活动以及习得的逃避行为范例。
这项工作将确定逃亡过程中关键皮质下大脑区域在裸盖菇素作用中的相对作用
行为并扩展裸盖菇素在临床治疗中的使用框架。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Pasha A Davoudian其他文献
Shared and distinct brain regions targeted for immediate early gene expression by ketamine and psilocybin
氯胺酮和裸盖菇素针对立即早期基因表达的共享和不同的大脑区域
- DOI:
10.1101/2022.03.18.484437 - 发表时间:
2022-03-20 - 期刊:
- 影响因子:0
- 作者:
Pasha A Davoudian;Ling;A. Kwan - 通讯作者:
A. Kwan
Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo
裸盖菇素在体内诱导额叶皮层树突棘快速持续生长
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:16.2
- 作者:
Ling;Clara Liao;Ian Gregg;Pasha A Davoudian;N. K. Savalia;Kristina Delagarza;A. Kwan - 通讯作者:
A. Kwan
Clinical overview of NMDA-R antagonists and clinical practice.
NMDA-R 拮抗剂的临床概述和临床实践。
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
Pasha A Davoudian;S. Wilkinson - 通讯作者:
S. Wilkinson
Connectomic features underlying diverse synaptic connection strengths and subcellular computation
连接组学特征是不同突触连接强度和亚细胞计算的基础
- DOI:
10.1101/2021.08.19.456845 - 发表时间:
2021-08-19 - 期刊:
- 影响因子:9.2
- 作者:
Tony X. Liu;Pasha A Davoudian;Kristyn M. Lizbinski;James M. Jeanne - 通讯作者:
James M. Jeanne
5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice
5-MeO-DMT 改变小鼠先天行为并促进结构神经可塑性
- DOI:
10.1101/2022.11.03.515044 - 发表时间:
2022-11-03 - 期刊:
- 影响因子:0
- 作者:
Sarah J. Jefferson;Ian Gregg;M. Dibbs;Clara Liao;Hao Wu;Pasha A Davoudian;Jeffrey S. Sprouse;Ale;er M. Sherwood;er;Alfred P. Kaye;C. Pittenger;A. Kwan - 通讯作者:
A. Kwan
Pasha A Davoudian的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
I-TRANSFER Improving TRansitions ANd outcomeS oF sEpsis suRvivors
I-TRANSFER 改善脓毒症幸存者的转变和结果
- 批准号:
10824878 - 财政年份:2023
- 资助金额:
$ 3.26万 - 项目类别:
Linking neural mechanisms of emotion and attention with naturalistic trauma symptom experience: An event-related potential and ecological momentary assessment study
将情绪和注意力的神经机制与自然创伤症状体验联系起来:事件相关电位和生态瞬时评估研究
- 批准号:
10679288 - 财政年份:2023
- 资助金额:
$ 3.26万 - 项目类别:
Feasibility of Using PET Imaging for Detection of Treatment-Induced Changes in Chronic Neuroinflammation Following TBI
使用 PET 成像检测 TBI 后治疗引起的慢性神经炎症变化的可行性
- 批准号:
10703823 - 财政年份:2023
- 资助金额:
$ 3.26万 - 项目类别:
COVID-19 Pandemic-related Changes in the Child Tax Credit and Effects on Behavioral Health for Medicaid-enrolled Adolescents
与 COVID-19 大流行相关的儿童税收抵免变化及其对参加医疗补助的青少年行为健康的影响
- 批准号:
10686628 - 财政年份:2023
- 资助金额:
$ 3.26万 - 项目类别:
Feasibility and Usability of a Spanish-Transcreated Pediatric Post-Transplant Adherence App (BMT4me)
西班牙翻译的儿科移植后依从性应用程序 (BMT4me) 的可行性和可用性
- 批准号:
10782256 - 财政年份:2023
- 资助金额:
$ 3.26万 - 项目类别: